Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Genes|July 10, 2019
The Foundation Fighting Blindness Plays an Essential and Expansive Role in Driving Genetic Research for Inherited Retinal DiseasesBen Shaberman, Todd DurhamTranslational Vision Science & Technology|August 29, 2020
Report from a Workshop on Accelerating the Development of Treatments for Inherited Retinal Dystrophies Associated with Mutations in the RDH12 GeneFrancesca Sofia, Silvia Cerolini, Todd DurhamCold Spring Harbor Perspectives in Medicine|January 23, 2023
The Importance of Natural History Studies in Inherited Retinal DiseasesAllison Ayala, Janet Cheetham, Todd Durham, et al.Cold Spring Harbor Perspectives in Medicine|October 11, 2022
Beyond the NEI-VFQ: Recent Experience in the Development and Utilization of Patient-Reported Outcomes for Inherited Retinal DiseasesTodd Durham, Judit Banhazi, Francesco Patalano, et al.Translational Vision Science & Technology|October 9, 2024
Current and Future Directions in Developing Effective Treatments for PRPH2-Associated Retinal Diseases: A Workshop ReportRadha Ayyagari, Shyamanga Borooah, Todd Durham, et al.Translational Vision Science & Technology|February 1, 2023
Identifying and Overcoming Challenges in Developing Effective Treatments for Usher 1B: A Workshop ReportShannon E Boye, Todd Durham, Amy Laster, et al.Journal of Drugs in Dermatology : JDD|October 27, 2018
A Phase 2 Controlled Study of SB206, a Topical Nitric Oxide-Releasing Drug for Extragenital Wart TreatmentStephen K Tyring, Theodore Rosen, Brian Berman, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 12, 2012
Long term effects of denufosol tetrasodium in patients with cystic fibrosisFelix Ratjen, Todd Durham, Tomas Navratil, et al.Journal of Drugs in Dermatology : JDD|August 21, 2018
A Phase 2, Controlled, Dose-Ranging Study of SB208, an Investigational Topical Nitric Oxide-Releasing Drug, for the Treatment of Tinea PedisBoni E Elewski, Leon H Kircik, Nathan Stasko, et al.Translational Vision Science & Technology|August 9, 2024
Report From the Second Global Scientific Conference on Clinical Trial Design and Outcome Measures for RDH12-Associated Inherited Retinal DegenerationSilvia Cerolini, Jean Bennett, Bart P Leroy, et al.Pageof 2